Will earnings report, end it’s winning streak? Applied Molecular Transport (NASDAQ:AMTI)

0
447

Earnings results for Applied Molecular Transport (NASDAQ:AMTI)

Applied Molecular Transport Inc. is estimated to report earnings on 11/10/2020. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 3 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.41.

Applied Molecular Transport last issued its earnings results on August 11th, 2020. The reported ($1.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.37) by $0.74. Applied Molecular Transport has generated $0.00 earnings per share over the last year. Applied Molecular Transport has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, November 10th, 2020 based off prior year’s report dates.

Analyst Opinion on Applied Molecular Transport (NASDAQ:AMTI)

3 Wall Street analysts have issued ratings and price targets for Applied Molecular Transport in the last 12 months. Their average twelve-month price target is $34.67, predicting that the stock has a possible upside of 14.64%. The high price target for AMTI is $38.00 and the low price target for AMTI is $32.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of “Buy.”

Applied Molecular Transport has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $34.67, Applied Molecular Transport has a forecasted upside of 14.6% from its current price of $30.24. Applied Molecular Transport has received no research coverage in the past 90 days.

Dividend Strength: Applied Molecular Transport (NASDAQ:AMTI)

Applied Molecular Transport does not currently pay a dividend. Applied Molecular Transport does not have a long track record of dividend growth.

Insiders buying/selling: Applied Molecular Transport (NASDAQ:AMTI)

In the past three months, Applied Molecular Transport insiders have not sold or bought any company stock. 48.95% of the stock of Applied Molecular Transport is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of Applied Molecular Transport (NASDAQ:AMTI

Earnings for Applied Molecular Transport are expected to grow in the coming year, from ($2.84) to ($2.06) per share.

More latest stories: here